The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index; 6 of the 89 sources its claims cite were checked for support.
Regulation of Lymphoid Enhancer Factor 1/T-Cell Factor by Mitogen-Activated Protein Kinase-Related Nemo-Like Kinase-Dependent Phosphorylation in Wnt/β-Catenin Signaling
Open accessAbstract
The Wnt/beta-catenin signaling pathway regulates many developmental processes by modulating gene expression. Wnt signaling induces the stabilization of cytosolic beta-catenin, which then associates with lymphoid enhancer factor and T-cell factor (LEF-1/TCF) to form a transcription complex that activates Wnt target genes. Previously, we have shown that a specific mitogen-activated protein (MAP) kinase pathway involving the MAP kinase kinase kinase TAK1 and MAP kinase-related Nemo-like kinase (NLK) suppresses Wnt signaling. In this study, we investigated the relationships among NLK, beta-catenin, and LEF-1/TCF. We found that NLK interacts directly with LEF-1/TCF and indirectly with beta-catenin via LEF-1/TCF to form a complex. NLK phosphorylates LEF-1/TCF on two serine/threonine residues located in its central region. Mutation of both residues to alanine enhanced LEF-1 transcriptional activity and rendered it resistant to inhibition by NLK. Phosphorylation of TCF-4 by NLK inhibited DNA binding by the beta-catenin-TCF-4 complex. However, this inhibition was abrogated when a mutant form of TCF-4 was used in which both threonines were replaced with valines. These results suggest that NLK phosphorylation on these sites contributes to the down-regulation of LEF-1/TCF transcriptional activity.
Overview
AI snapshot
Written from the paper’s full text.
TL;DR
NLK directly binds LEF-1/TCF and phosphorylates conserved central serine/threonine residues, thereby inhibiting β-catenin–TCF DNA binding and LEF-1/TCF transcriptional activity. β-Catenin associates with NLK indirectly through LEF-1/TCF, and β-catenin enhances NLK phosphorylation of TCF-4.
Key findings
- NLK interacted directly with LEF-1/TCF but not appreciably with β-catenin; LEF-1/TCF bridged β-catenin to NLK, and β-catenin enhanced NLK phosphorylation of TCF-4 in vitro.
- NLK phosphorylated LEF-1 at Thr-155 and Ser-166 and TCF-4 at Thr-178 and Thr-189; LEF-1(2A) and TCF-4(2V) mutants showed greatly reduced NLK phosphorylation.
- LEF-1(2A) enhanced Wnt-1-induced TOPFLASH reporter activity more strongly than wild-type LEF-1 and was resistant to NLK inhibition; Wnt-1 alone induced the reporter about fourfold.
- NLK phosphorylation of TCF-4 inhibited DNA binding by the β-catenin–TCF-4 complex, while TCF-4(2V) enhanced DNA binding and remained bound even with NLK expression.
Methods
- Biochemical and cell-based study using human embryonic kidney 293 and HeLa cells, with transfected Flag-NLK, T7/HA-LEF-1, TCF-4, β-catenin, and mutant constructs.
- Assays included yeast two-hybrid, coimmunoprecipitation/immunoblotting, in vitro kinase assays with [γ-32P]ATP, TOPFLASH/FOPFLASH luciferase reporter assays, and gel mobility shift assays.
- Main analysis compared wild-type versus phosphorylation-site mutants LEF-1(2A) and TCF-4(2V) for NLK binding, phosphorylation, β-catenin association, transcriptional activity, and DNA binding.
Limitations
- Stated in the paper: weak residual phosphorylation of LEF-1(2A) and TCF-4(2V) suggests additional NLK phosphorylation sites may exist; NLK overexpression failed to suppress endogenous LEF-1/TCF-dependent transcription in HeLa cells, suggesting a resistant complex.
- Evident from the text: mechanistic conclusions rely heavily on overexpression in 293/HeLa cell lines and in vitro kinase/gel-shift assays, with no vertebrate in vivo requirement for these phosphorylation sites tested here.
- Evident from the text: the mechanism by which NLK phosphorylation distal to the DNA-binding domain inhibits β-catenin–TCF-4 DNA binding was not determined.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
57 Own result · 54 No full text of the sources · 41 Own interpretation · 2 Supported so far · 2 Partly supported · 1 Not supported · 1 Not checked yet · 1 No basis given · accuracy not yet measured
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Indeed, WRM-1, which is only 19% identical to vertebrate β-catenin, does not bind to the POP-1 β-catenin-binding domain per se but weakly binds full-length POP-1 (14, 19, 22).”
What the sources say
- Not checked — no full text of the sourcecites [14] source
- Disputedcites [19] sourceExperimental — accuracy not yet measured
The percentage-identity table in the section on β-catenin family members across species (page unavailable) gives 17% identity between WRM-1 and human β-catenin, not 19%. The Methods section says these percentages were calculated from sequence alignments. (LLM, conf=0.90)
Checked by a reasoning model — may be wrong.
- Not checked — no full text of the sourcecites [22] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“HeLa cells, which contain low levels of endogenous LEF-1/TCF (10).”
What the sources say
- Partly supportedcites [10] sourceExperimental — accuracy not yet measured
The Results (page not provided) describe HeLa cells as not expressing LEF-1, supporting low endogenous LEF-1 relative to LEF-1-expressing Jurkat cells. The passage does not establish the level of endogenous TCF in HeLa cells. (LLM, conf=0.82)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Indeed, WRM-1, which is only 19% identical to vertebrate β-catenin, does not bind to the POP-1 β-catenin-binding domain per se but weakly binds full-length POP-1 (14, 19, 22).”
What the sources say
- Not checked — no full text of the sourcecites [14] source
- Partly supportedcites [19] sourceExperimental — accuracy not yet measured
In the protein-interaction results (page unavailable), WRM-1 interacts weakly with POP-1 even after deletion of POP-1’s amino-terminal β-catenin-binding region. This supports an interaction that does not require that region, but the paper does not test whether WRM-1 can bind the region itself; it presents a different mode of interaction as a suggestion, not a categorical finding. (LLM, conf=0.84)
- Not checked — no full text of the sourcecites [22] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Indeed, WRM-1, which is only 19% identical to vertebrate β-catenin, does not bind to the POP-1 β-catenin-binding domain per se but weakly binds full-length POP-1 (14, 19, 22).”
What the sources say
- Not checked — no full text of the sourcecites [14] source
- Supportedcites [19] source
In the β-catenin family members across species section, the POP-1 interaction table records a weak WRM-1 interaction with full-length POP-1; the accompanying text explicitly calls it a weak interaction. The finding comes from a yeast interaction assay, so “binds” is a paraphrase of that result. (LLM, conf=0.92)
- Not checked — no full text of the sourcecites [22] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“NLK phosphorylates LEF-1/TCF on two serine/threonine residues located in its central region.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mutation of both residues to alanine enhanced LEF-1 transcriptional activity and rendered it resistant to inhibition by NLK.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Mutation of both residues to alanine enhanced LEF-1 transcriptional activity and rendered it resistant to inhibition by NLK.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that NLK interacts directly with LEF-1/TCF and indirectly with β-catenin via LEF-1/TCF to form a complex.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“We found that NLK interacts directly with LEF-1/TCF and indirectly with β-catenin via LEF-1/TCF to form a complex.”
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
A result the paper reports from its own data — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“Phosphorylation of TCF-4 by NLK inhibited DNA binding by the β-catenin-TCF-4 complex.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Probably not a substantial claim. 17
- It may state two separate claims as one. 17
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“β-Catenin then translocates into the nucleus, where it forms a complex with the HMG box class of transcription factors, including lymphoid enhancer factor 1 (LEF-1) and T-cell factor (TCF), and activates the transcription of its target genes (5, 17, 20).”
What the sources say
- Supportedcites [5] source
The “Binding of Arm/β-catenin to Tcf-LEF-1” section (page not specified) says β-catenin accumulates in the nucleus after Wnt stimulation, binds HMG-box factors of the Tcf-LEF-1 family, and forms complexes that activate transcription. This supports the cited paraphrase. (LLM, conf=0.93)
- Supportedcites [17] source
The section on nuclear β-catenin says LEF-1 and XTcf-3, both HMG-box factors, bind β-catenin and translocate it to the nucleus. The Figure 3 discussion says the resulting complex binds DNA and alters transcription; the paper also reports transactivation of a reporter gene. Page numbers are not supplied in our copy. (LLM, conf=0.91)
- Not checked — no full text of the sourcecites [20] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. It may state two separate claims as one.
- Supported
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“These results suggest that Wnt signaling and the MAPK-related cascade both act to control polarity by regulating POP-1 and that integration of two signals occurs at the level of complex formation between WRM-1 and LIT-1.”
What the sources say
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“TAK1 functions upstream of NLK and enhances NLK kinase activity.”
What the sources say
- Not checked — no full text of the sourcecites [13] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Active NLK phosphorylates LEF-1/TCF and prevents the β-catenin-TCF complex from binding to DNA, thereby inhibiting the ability of β-catenin-TCF to activate transcription.”
What the sources say
- Not checked — no full text of the sourcecites [13] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“LIT-1 interacts directly with WRM-1, and this complex can phosphorylate POP-1 in a LIT-1 kinase domain-dependent manner, indicating that these pathways converge at WRM-1 (22).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Consistent with this, ectopic expression of NLK blocks double-axis formation in Xenopus induced by overexpression of β-catenin but not by the downstream components siamois and twin (13).”
What the sources say
- Not checked — no full text of the sourcecites [13] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
The paper states this without a source or data behind it here, so there is nothing to check it against. The quote shows it is in the paper.
In the paper
“In this complex, LEF-1/TCF provides the DNA-binding domain while β-catenin contributes the transactivation domain, allowing the activation of LEF-1/TCF target genes.”
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Although LEF-1/TCF family members share overall sequence similarity, these two regions are particularly conserved (18).”
What the sources say
- Not checked — no full text of the sourcecites [18] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In C. elegans, WRM-1 and LIT-1 appear to form a stable protein complex in vivo (22).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“In C. elegans, WRM-1 (β-catenin) directly interacts with and activates LIT-1 (NLK).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Active LIT-1 then phosphorylates WRM-1 and POP-1 (LEF-1/TCF) (22).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“S/TP motifs are consensus sites for MAPK phosphorylation (31).”
What the sources say
- Not checked — no full text of the sourcecites [31] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“LEF-1/TCF has been shown to form a complex with β-catenin in response to Wnt stimulation (2, 4, 18, 34).”
What the sources say
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim.
In the paper
“Although LEF-1/TCF family members share overall sequence similarity, these two regions are particularly conserved (18).”
What the sources say
- Not checked — no full text of the sourcecites [18] source
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“However, these results do not completely rule out the possibility that these residues play a role in the association of LEF-1 and TCF-4 with NLK.”
hedged- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“WRM-1 activates the LIT-1 protein kinase, leading to phosphorylation of WRM-1, LIT-1, and POP-1.”
What the sources say
- Not checked — no full text of the sourcecites [22] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“suggesting that the LEF-1(2A) and TCF-4(2V) mutations abrogate phosphorylation per se and do not otherwise affect the interaction with NLK in vivo.”
hedgeddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The LEF-1 protein contains a COOH-terminal HMG DNA-binding domain and an NH2-terminal β-catenin-binding domain.
In the paper
“Rocheleau et al. (22) have demonstrated that the WRM-1 protein binds to and activates LIT-1.”
What the sources say
- Not checked — no full text of the sourcecites [22] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“T-cell polarity is controlled by LIN-44 (Wnt), LIN-17 (Frizzled receptor), and POP-1 (7, 8, 9, 26).”
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“These findings indicate that the components of the Wnt pathway in C. elegans and vertebrates are similar but have different activities.”
hedgedcorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
- Rests on an assumption: The components of the Wnt pathway (β-catenin, LEF-1/TCF, NLK) are conserved in vertebrates.
In the paper
“POP-1 plays a negative role in Wnt signaling and is inhibited by WRM-1 through LIT-1-mediated phosphorylation of POP-1 (22).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A claim is checked only against the cited paper’s full text, never its abstract, and none is available for its sources.
In the paper
“The β-catenin-LEF-1/TCF complex, in turn, activates Wnt target genes in the nucleus (2, 4, 18, 34).”
What the sources say
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“On the other hand, β-catenins can stably bind to LEF-1/TCF (2).”
What the sources say
- Not checked — no full text of the sourcecites [2] source
plaincorrelational- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
A conclusion the paper draws from its own results — it cites no other source for it, so there is none to check. The quote shows it is in the paper.
In the paper
“It is likely that functionally conserved serine and threonine residues are also present between the β-catenin-binding domain and the DNA-binding domain of LEF-1/TCF that regulate its activity.”
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“The C. elegans LIT-1 protein interacts directly with WRM-1, and this complex can phosphorylate POP-1 in a manner that requires the LIT-1 kinase domain (22).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it.
In the paper
“This activation leads to the phosphorylation of POP-1 and apparent changes in its subcellular localization (22).”
What the sources say
- Not checked — no full text of the sourcecites [22] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“We have previously shown that NLK phosphorylates TCF-4 and prevents the β-catenin-TCF-4 complex from binding DNA (13).”
What the sources say
- Not checked — no full text of the sourcecites [13] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“it has the potential both to regulate the axis-determining activity of LEF-1/TCF and to modulate other potential functions of LEF-1/TCF at later stages of development, such as neural patterning or mesoderm development (11).”
What the sources say
- Not checked — no full text of the sourcecites [11] source
hedgedconditional- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Mechanistically, NLK directly interacts with and phosphorylates TCF-4.”
What the sources say
- Not checked — no full text of the sourcecites [13] source
plaindirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
It may state two separate claims as one.
In the paper
“Such regulation of DNA binding by phosphorylation of sequence-specific transcription factors has been well documented in several cases and can act both positively and negatively (3).”
What the sources say
- Not checked — no full text of the sourcecites [3] source
boosteddirect- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: fails — The paper’s conclusions may not depend on it.
- Based: passes — The paper gives a reason why it holds.
Probably not a substantial claim. The paper’s conclusions may not depend on it. It may state two separate claims as one.
The paper relies on this without support.
In mammalian cells, the relationships among NLK, β-catenin, and LEF-1/TCF are not well understood.
“On the other hand, in mammalian cells, the relationships among NLK, β-catenin, and LEF-1/TCF are not well understood.”
The paper relies on this without support.
The LEF-1 protein contains a COOH-terminal HMG DNA-binding domain and an NH2-terminal β-catenin-binding domain.
“The LEF-1 protein contains a COOH-terminal HMG DNA-binding domain and an NH2-terminal β-catenin-binding domain (Fig. 3A).”
The paper relies on this without support.
The components of the Wnt pathway (β-catenin, LEF-1/TCF, NLK) are conserved in vertebrates.
“These components are conserved in vertebrates.”
The paper relies on this without support.
In the early C. elegans embryo, Wnt signaling controls anterior-posterior cell polarity in the EMS blastomere.
“In the early C. elegans embryo, Wnt signaling controls anterior-posterior cell polarity in the EMS blastomere.”
The paper relies on this without support.
The β-catenin-related factor WRM-1 and the NLK-related kinase LIT-1 are effectors of Wnt signaling in the early C. elegans embryo.
“The β-catenin-related factor WRM-1 and the NLK-related kinase LIT-1 are effectors of this signaling pathway.”
The paper relies on this without support.
C. elegans Wnt signaling controls anterior-posterior cell polarity in postembryonic T blast cells.
“C. elegans Wnt signaling also controls anterior-posterior cell polarity in postembryonic T blast cells.”
The paper relies on this without support.
In many cases in which phosphorylation inhibits DNA binding, the phosphorylation sites are located either within or near the DNA-binding domain.
“In many cases in which phosphorylation inhibits DNA binding, the phosphorylation sites are located either within or near the DNA-binding domain.”
The paper relies on this without support.
In such cases, phosphorylation interferes with DNA binding by electrostatic repulsion between phosphate groups on the protein and the DNA.
“In such cases, it is likely that phosphorylation interferes with DNA binding by electrostatic repulsion between phosphate groups on the protein and the DNA.”
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In 293 cells, Flag-NLK suppressed reporter gene expression, a finding in agreement with previous reports.17), 34)”
From Mammalian Nemo-like kinase enhances .BETA.-catenin-TCF transcription activity in human osteosarcoma and neuroblastoma cells (2007) · cites this paper as [34]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ishitani et al. suggested that DNA binding of LEF1 decreased with its phosphorylation at threonine 155 and serine 166 by overexpression of NLK.17), 34)”
From Mammalian Nemo-like kinase enhances .BETA.-catenin-TCF transcription activity in human osteosarcoma and neuroblastoma cells (2007) · cites this paper as [34]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“In vertebrates, NLK is considered to be a negative regulator of the Wnt signalling pathway.”
From Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies (2020) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“This phosphorylation prevents DNA binding of the β-catenin-TCF4 complex and limits β-catenin-mediated target gene transcription through TCF/LEF [16,17].”
From Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies (2020) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“Previous studies showed that NLK can regulate the transcriptional activity of the β-catenin-LEF/TCF complex by directly phosphorylating TCF4.”
From Nemo-Like Kinase in Development and Diseases: Insights from Mouse Studies (2020) · cites this paper as [17]
The cited source says what the claim attributes to it.
In the citing paper
“NLK-KN is a lysine to methionine substitution at residue 155 (K155M) and is defective for kinase activity (Ishitani et al., 2003; Ishitani et al., 2011).”
From Polyglutamine Disease Toxicity Is Regulated by Nemo-like Kinase in Spinocerebellar Ataxia Type 1 (2013) · cites this paper as Ishitani et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ DISCUSSION
“Site-directed mutagenesis of these conserved serine and threonine residues abrogated NLK-mediated phosphorylation in vitro and in vivo.”
§ RESULTS
“The fact that some weak phosphorylation was still observed with the LEF-1(2A) and TCF-4(2V) mutant forms suggests that LEF-1 and TCF-4 may contain additional NLK phosphorylation sites.”
Citations
Cites
Functional interaction of β-catenin with the transcription factor LEF-1
Behrens, J., von Kries, J. P., Kühl, M., Bruhn, L., Wedlich, D., Grosschedl, R., & Birchmeier, W. (1996) · Nature · doi:10.1038/382638a0 · Cited by 2,912
β‐catenin is a target for the ubiquitin–proteasome pathway
Aberle, H., Bauer, A., Stappert, J., Kispert, A., & Kemler, R. (1997) · The EMBO Journal · doi:10.1093/emboj/16.13.3797 · Cited by 2,586
Wnt signaling: a common theme in animal development
Cadigan, K. M., & Nusse, R. (1997) · Genes & Development · doi:10.1101/gad.11.24.3286 · Cited by 2,567
XTcf-3 Transcription Factor Mediates β-Catenin-Induced Axis Formation in Xenopus Embryos
Molenaar, M., van de Wetering, M., Oosterwegel, M., Peterson-Maduro, J., Godsave, S., Korinek, V., Roose, J., Destrée, O., & Clevers, H. (1996) · Cell · doi:10.1016/s0092-8674(00)80112-9 · Cited by 1,824
Wetering, M. L. V. D., Cavallo, R. A., Dooijes, D., van Beest, M., van Es, J. V., Loureiro, J., Ypma, A., Hursh, D., Jones, T. L., Bejsovec, A., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)81925-x · Cited by 1,347
Regulation of transcription by MAP kinase cascades
Treisman, R. (1996) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(96)80067-6 · Cited by 1,296
Wnt Signaling in Oncogenesis and Embryogenesis--a Look Outside the Nucleus
Peifer, M., & Polakis, P. (2000) · Science · doi:10.1126/science.287.5458.1606 · Cited by 1,253
Ikeda, S., Kishida, S., Yamamoto, H., Murai, H., Koyama, S., & Kikuchi, A. (1998) · The EMBO Journal · doi:10.1093/emboj/17.5.1371 · Cited by 1,248
Drosophila Tcf and Groucho interact to repress Wingless signalling activity
Cavallo, R. A., Cox, R. T., Moline, M. M., Roose, J., Polevoy, G. A., Clevers, H., Peifer, M., & Bejsovec, A. (1998) · Nature · doi:10.1038/26982 · Cited by 730
Signal Transduction and the Control of Gene Expression
Brivanlou, A. H., & Darnell, J. E. (2002) · Science · doi:10.1126/science.1066355 · Cited by 699
Research works printed but not linked: 1
- Shin T. H., 1999, Cell, 4, 275
Cited by
Sorted by citations
The Wnt Signaling Pathway in Development and Disease
Logan, C. Y., & Nusse, R. (2004) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.20.010403.113126 · Cited by 5,325
“The phosphorylation of TCF/LEF by activated Nemo is thought to diminish the DNA-binding affinity of the β-catenin/TCF/LEF complex, thereby affecting transcriptional regulation of Wnt target genes (Ishitani et al. 1999, 2003).”
BackgroundWnt Signaling: Multiple Pathways, Multiple Receptors, and Multiple Transcription Factors
Gordon, M. D., & Nusse, R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.r600015200 · Cited by 1,333
Purified Wnt5a Protein Activates or Inhibits β-Catenin–TCF Signaling Depending on Receptor Context
Mikels, A. J., & Nusse, R. (2006) · PLoS Biology · doi:10.1371/journal.pbio.0040115 · Cited by 1,244
“This phosphorylation of TCF/LEF prevents the b-catenin–TCF/LEF transcriptional complex from binding to DNA [17,18,36].”
BackgroundWnt signaling in osteoblasts and bone diseases
Westendorf, J. J., Kahler, R. A., & Schroeder, T. M. (2004) · Gene · doi:10.1016/j.gene.2004.06.044 · Cited by 820
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.02.004 · Cited by 536
Mammalian Ryk Is a Wnt Coreceptor Required for Stimulation of Neurite Outgrowth
Lu, W., Yamamoto, V. N., Ortega, B., & Baltimore, D. (2004) · Cell · doi:10.1016/j.cell.2004.09.019 · Cited by 466
Diversity of LEF/TCF action in development and disease
Arce, L., Yokoyama, N. N., & Waterman, M. L. (2006) · Oncogene · doi:10.1038/sj.onc.1210056 · Cited by 449
“In vertebrates, NLK phosphorylates LEF-1 and TCF-4 and in C. elegans, the orthologous LIT-1 phosphorylates POP-1 (Ishitani et al., 2003; Lo et al., 2004).”
BackgroundInfluentialNinomiya‐Tsuji, J., Kajino, T., Ono, K., Ohtomo, T., Matsumoto, M., Shiina, M., Mihara, M., Tsuchiya, M., & Matsumoto, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m207453200 · Cited by 407
Self-citationIdentification of Modulators of TRAIL-Induced Apoptosis via RNAi-Based Phenotypic Screening
Aza‐Blanc, P., Cooper, C. L., Wagner, K., Batalov, S., Deveraux, Q. L., & Cooke, M. P. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00348-4 · Cited by 342
Atypical mitogen-activated protein kinases: Structure, regulation and functions
Coulombe, P., & Meloche, S. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2006.11.001 · Cited by 298
Wnt signaling in triple-negative breast cancer
Pohl, S., Brook, N., Agostino, M., Arfuso, F., Kumar, A. P., & Dharmarajan, A. (2017) · Oncogenesis · doi:10.1038/oncsis.2017.14 · Cited by 305
Transcriptional Regulation of Wnt/β-Catenin Pathway in Colorectal Cancer
Bian, J., Dannappel, M., Wan, C., & Firestein, R. (2020) · Cells · doi:10.3390/cells9092125 · Cited by 261
Common Activation of Canonical Wnt Signaling in Pancreatic Adenocarcinoma
di Magliano, M. P., Biankin, A. V., Heiser, P. W., Cano, D. A., Gutiérrez, P. J. A., Deramaudt, T. B., Segara, D., Dawson, A. C., Kench, J. G., Henshall, S. M., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0001155 · Cited by 236
“complex is regulated at different levels, such as accumulation and localization of b2CATENIN [42], interaction between the two factors, and ability of TCF4 to bind DNA [43].”
BackgroundRegulation of Wnt/β-catenin signaling by posttranslational modifications
Gao, C., Xiao, G., & Hu, J. (2014) · Cell & Bioscience · doi:10.1186/2045-3701-4-13 · Cited by 236
“TCF/LEF Phosphorylation T155/S166 (LEF-1) Nemo-like kinase Inhibits DNA binding of TCF/β-catenin complex [105,106]”
BackgroundWnt/beta-Catenin Signaling and Small Molecule Inhibitors
Voronkov, A. E., & Krauss, S. J. K. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804581837 · Cited by 227
Pérez, V. D. J., Alastalo, T., Wu, J., Axelrod, J. D., Cooke, J. P., Amieva, M. R., & Rabinovitch, M. (2009) · The Journal of Cell Biology · doi:10.1083/jcb.200806049 · Cited by 216
The way Wnt works: Components and mechanism
Saito‐Diaz, K., Chen, T. W., Wang, X., Thorne, C. A., Wallace, H. A., Page, A. W., & Lee, E. N. (2012) · Growth Factors · doi:10.3109/08977194.2012.752737 · Cited by 223
“Wnt-induced nuclear b-catenin accumulation leads to an interaction with the TCF/LEF family of DNAbound transcription factors that are critical for Wnt-mediated gene regulation (Behrens et al. 1996; Molenaar et al. 1996).”
BackgroundInfluentialβ-Catenin and Tcfs in Mammary Development and Cancer
Hatsell, S., Rowlands, T., Hiremath, M., & Cowin, P. (2003) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1025944723047 · Cited by 209
“The TGF-β pathway impinges via smads and by TAK activation of nemo-like kinase (NLK), which phosphorylates TCFs, disrupting their DNA-binding and transcriptional capacity (94).”
BackgroundCavodeassi, F., Carreira-Barbosa, F., Young, R., Concha, M. L., Allende, M. L., Houart, C., Tada, M., & Wilson, S. W. (2005) · Neuron · doi:10.1016/j.neuron.2005.05.026 · Cited by 207
Ror2 Receptor Requires Tyrosine Kinase Activity to Mediate Wnt5A Signaling
Mikels, A. J., Minami, Y., & Nusse, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.041715 · Cited by 182
Calcium signaling in vertebrate embryonic patterning and morphogenesis
Slusarski, D. C., & Pelegri, F. (2007) · Developmental Biology · doi:10.1016/j.ydbio.2007.04.043 · Cited by 178
“…as has been proposed in various cellular systems where CaMKII acts through a mitogen-activated protein kinase (MAPK) pathway to directly regulate the activity of Tcf family transcription factors (Ishitani et al., 1999; Meneghini et al., 1999; Rocheleau et al., 1999; Ishitani et al., 2003a,b).”
BackgroundWnt signaling: multiple functions in neural development
Ille, F., & Sommer, L. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-4552-2 · Cited by 180
Baarsma, H. A., Königshoff, M., & Gosens, R. (2013) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2013.01.002 · Cited by 179
“For instance, the Nemo-like kinase (NLK) antagonizes the action of TCF/LEF by phosphorylation of a domain distinct from the HMG-DNA binding domain; however, this modification does inhibit DNA binding (figure 2) (Ishitani et al., 2003).”
BackgroundThe Role of Wnt Signalling in Angiogenesis.
Olsen, J. J., Pohl, S., Deshmukh, A. P., Visweswaran, M., Ward, N. C., Arfuso, F., Agostino, M., & Dharmarajan, A. (2017) · Europe PMC (PubMed Central) · Cited by 174
The Wnt signaling pathway: Aging gracefully as a protectionist?
Maiese, K., Li, F., Chong, Z. Z., & Shang, Y. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.01.004 · Cited by 171
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript”
BackgroundTCF/LEF Transcription Factors: An Update from the Internet Resources
Hrčkulák, D., Kolář, M., Strnad, H., & Kořínek, V. (2016) · Cancers · doi:10.3390/cancers8070070 · Cited by 173
“Similarly, LEF1 and TCF7L2 DNA binding is abrogated by phosphorylation of their central region by mitogen-activated (MAP) kinase-related nemo like kinase (NLK) [41].”
BackgroundRegulation of TCF3 by Wnt-Dependent Phosphorylation during Vertebrate Axis Specification
Hikasa, H., Ezan, J., Itoh, K., Li, X., Klymkowsky, M. W., & Sokol, S. Y. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.09.005 · Cited by 165
“Whereas the P2 and P4 site have not been previously detected, the P3 site corresponds to the sites in LEF1 and TCF4 that are phosphorylated by mammalian NLK in vitro (Ishitani et al., 2003; Ishitani et al., 1999; Kanei-Ishii et al., 2004; Smit et al., 2004).”
BackgroundRegulation of Wnt/β‐catenin signaling by protein kinases
Verheyen, E. M., & Gottardi, C. J. (2009) · Developmental Dynamics · doi:10.1002/dvdy.22019 · Cited by 165
Nawshad, A., & Hay, E. D. (2003) · The Journal of Cell Biology · doi:10.1083/jcb.200306024 · Cited by 159
“There may be disadvantages in using -catenin to activate LEF1 in some systems (Ishitani et al., 2003).”
BackgroundWnt signaling and skeletal development
Liu, F., Kohlmeier, S. E., & Wang, C.-Y. (2007) · Cellular Signalling · doi:10.1016/j.cellsig.2007.11.011 · Cited by 162
Winding through the WNT pathway during cellular development and demise.
Li, F., Chong, Z. Z., & Maiese, K. (2006) · PubMed · doi:10.14670/hh-21.103 · Cited by 154
Stress in the brain: novel cellular mechanisms of injury linked to Alzheimer's disease
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2004.11.005 · Cited by 152
Kidd, A. R., Miskowski, J. A., Siegfried, K. R., Sawa, H., & Kimble, J. E. (2005) · Cell · doi:10.1016/j.cell.2005.03.029 · Cited by 144
The Epithelial-to-Mesenchymal Transition in Breast Cancer: Focus on Basal-Like Carcinomas
Fedele, M., Cerchia, L., & Chiappetta, G. (2017) · Cancers · doi:10.3390/cancers9100134 · Cited by 146
“This non-canonical Wnt pathway antagonizes canonical Wnt/β-catenin signaling by activation of Nemo-like kinase, which phosphorylates TCF4 and prevents the β-catenin–TCF4 complex from binding to DNA [49].”
BackgroundInfluentialLo, M.-C., Gay, F., Odom, R., Shi, Y., & Lin, R. (2004) · Cell · doi:10.1016/s0092-8674(04)00203-x · Cited by 138
Golan, T., Yaniv, A., Bafico, A., Liu, G., & Gazit, A. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m306421200 · Cited by 133
Ishitani, T., Hirao, T., Suzuki, M., Isoda, M., Ishitani, S., Harigaya, K., Kitagawa, M., Matsumoto, K., & Itoh, M. (2010) · Nature Cell Biology · doi:10.1038/ncb2028 · Cited by 131
Self-citationHOTAIR is a therapeutic target in glioblastoma
Zhou, X., Ren, Y., Zhang, J., Zhang, K., Zhang, K., Han, L., Kong, L., wei, J., Luyue, C., Yang, J., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3229 · Cited by 126
“Among these differentially expressed genes, NLK is known to be an important modulator of the β-catenin pathway by affecting the binding of the β-catenin/TCF/LEF complex to its target DNA sequence by phosphorylating LEF1 [21, 38, 39].”
BackgroundShy, B. R., Wu, C.-I., Khramtsova, G. F., Zhang, J. Y., Olopade, O. I., Goss, K. H., & Merrill, B. J. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.06.001 · Cited by 124
“Interestingly, work in other systems demonstrated mobility shifts caused by b-catenin-dependent phosphorylation Cell Reports of Tcf7l1/Tcf3 proteins by homeodomain-interacting protein kinase 2 (HipK2) (Hikasa et al., 2010; Hikasa and Sokol, 2011) and nemo-like kinase (NLK) (Ishitani et al., 1999, 2003).”
BackgroundInfluentialTran, H., Hamada, F., Schwarz, T., & Bienz, M. (2008) · Genes & Development · doi:10.1101/gad.463208 · Cited by 122
“These results argue that Trabid is neither required for the activity of LEF1 itself (or of its regulators, such as TAK1/NEMOlike kinase; Ishitani et al. 2003) nor for its natural coactivators or those recruited by the VP16 TAD.”
BackgroundA New Look at TCF and β-Catenin through the Lens of a Divergent C. elegans Wnt Pathway
Phillips, B. T., & Kimble, J. E. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.07.002 · Cited by 119
Differential inhibition of Wnt‐3a by Sfrp‐1, Sfrp‐2, and Sfrp‐3
Galli, L. M., Barnes, T. L., Cheng, T. L., Acosta, L., Anglade, A., Willert, K., Nusse, R., & Burrus, L. W. (2006) · Developmental Dynamics · doi:10.1002/dvdy.20681 · Cited by 117
“…in L Cells In vertebrates, Wnt ligands signal through multiple pathways, including a -catenin-dependent pathway and several -catenin-independent pathways (Ishitani et al., 1999, 2003; Kuhl et al., 2000, 2001; Topol et al., 2003; Westfall et al., 2003; Logan and Nusse, 2004; Smit et al., 2004).”
BackgroundInfluentialRoles of Wnt signals in bone resorption during physiological and pathological states
Maeda, K., Takahashi, N., & Kobayashi, Y. (2012) · Journal of Molecular Medicine · doi:10.1007/s00109-012-0974-0 · Cited by 118
Wang, K., Wang, X., Zou, J., Zhang, A., Wan, Y., Pu, P., Song, Z., Qian, C., Chen, Y., Yang, S., et al. (2013) · Neuro-Oncology · doi:10.1093/neuonc/not004 · Cited by 117
Wnt signalling and cancer stem cells
Espada, J., Blanco, M., Díaz‐Prado, S., & Médina, V. (2009) · Clinical & Translational Oncology · doi:10.1007/s12094-009-0380-4 · Cited by 116
Dysregulation of Hedgehog, Wnt and Notch signalling pathways in breast cancer.
Zardawi, S. J., O'Toole, S. A., Sutherland, R. L., & Musgrove, E. A. (2009) · PubMed · doi:10.14670/hh-24.385 · Cited by 111
“Canonical Wnt signalling is also negatively regulated by the Wnt/Ca2+ pathway (Ishitani et al., 2003).”
BackgroundWnt Activates the Tak1/Nemo-like Kinase Pathway
Smit, L., Baas, A. F., Kuipers, J., Korswagen, H. C., van de Wetering, M., & Clevers, H. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m307801200 · Cited by 109
Wnt Signaling: Physiology and Pathology
Prunier, C., Hocevar, B. A., & Howe, P. H. (2004) · Growth Factors · doi:10.1080/08977190410001720860 · Cited by 109
“Both the MAP kinase kinase kinase TAK1 and MAP kinase-related Nemo-like kinase (NLK) have been shown to suppress Wnt signaling (Ishitani et al., 1999; 2003a,b).”
BackgroundEkici, A. B., Hilfinger, D., Jatzwauk, M., et al. (2010) · Molecular Syndromology · doi:10.1159/000319859 · Cited by 106
Phosphorylation of TCF Proteins by Homeodomain-interacting Protein Kinase 2
Hikasa, H., & Sokol, S. Y. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.185280 · Cited by 102
Huang, S., Shetty, P. V., Robertson, S. M., & Lin, R. (2007) · Development · doi:10.1242/dev.008268 · Cited by 99
“Supporting this possibility, phosphorylation of TCF proteins by nemo-like kinase (NLK) has been reported to inhibit the DNA-binding activity of TCFs (Ishitani et al., 2003) and to enhance transcription of Wnt targets (Thorpe and Moon, 2004).”
BackgroundHarwood, B. N., Cross, S. K., Radford, E. E., Haac, B. E., & de Vries, W. N. (2008) · Developmental Dynamics · doi:10.1002/dvdy.21491 · Cited by 99
Wnt3a signaling within bone inhibits multiple myeloma bone disease and tumor growth
Qiang, Y., Shaughnessy, J. D., & Yaccoby, S. (2008) · Blood · doi:10.1182/blood-2007-10-120253 · Cited by 97
Maduro, M., Kasmir, J. J., Zhu, J., & Rothman, J. H. (2005) · Developmental Biology · doi:10.1016/j.ydbio.2005.06.022 · Cited by 92
“, 1999), and phosphorylation has been shown to disrupt the DNA-binding properties of other TCF/Lef factors (Ishitani et al., 2003).”
BackgroundVital Elements of the Wnt-Frizzled Signaling Pathway in the Nervous System
Li, F., Chong, Z. Z., & Maiese, K. (2005) · Current Neurovascular Research · doi:10.2174/156720205774322557 · Cited by 93
The ubiquitin specific protease 4 (USP4) is a new player in the Wnt signalling pathway
Zhao, B., Schlesiger, C., Masucci, M. G., & Lindsten, K. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00682.x · Cited by 93
“Activated Nlk promotes the phosphorylation of TCF/LEF bound to catenin, causing an overall inhibition of transcription [22].”
BackgroundFukuyama, R., Niculaita, R., Ng, K. P., Obusez, E. C., Sanchez, J., Kalady, M. F., Aung, P. P., Casey, G., & Sizemore, N. (2008) · Oncogene · doi:10.1038/onc.2008.204 · Cited by 88
Nrarp functions to modulate neural-crest-cell differentiation by regulating LEF1 protein stability
Ishitani, T., Matsumoto, K., Chitnis, A. B., & Itoh, M. (2005) · Nature Cell Biology · doi:10.1038/ncb1311 · Cited by 89
Self-citationChong, Z. Z., & Maiese, K. (2004) · PubMed · doi:10.14670/hh-19.495 · Cited by 84
“The free ß-catenin translocates to the nucleus where it activates lymphocyte enhancer factor (Lef) and T cell factor (Tcf) (Ishitani et al., 2003) leading to stimulation of Wnt – response genes.”
Backgroundnemo-like kinase is an essential co-activator of Wnt signaling during early zebrafish development
Thorpe, C. J., & Moon, R. T. (2004) · Development · doi:10.1242/dev.01171 · Cited by 84
NLK positively regulates Wnt/β‐catenin signalling by phosphorylating LEF1 in neural progenitor cells
Ota, S., Ishitani, S., Shimizu, N., Matsumoto, K., Itoh, M., & Ishitani, T. (2012) · The EMBO Journal · doi:10.1038/emboj.2012.46 · Cited by 82
“However, co-expression of b -catenin D with the LEF1-2E mutant, which mimics constitutive phosphorylation, was still able to activate TOPFLASH reporter activity in HeLa cells (Supplementary Figure S12A).”
InfluentialSelf-citationSOX11: friend or foe in tumor prevention and carcinogenesis?
Yang, Z. P., Jiang, S., Lu, C., Ji, T., Yang, W., Li, T. X., Lv, J., Hu, W., Yang, Y., & Jin, Z. (2019) · Therapeutic Advances in Medical Oncology · doi:10.1177/1758835919853449 · Cited by 81
Wnt signaling and neural stem cells: caught in the Wnt web
Michaelidis, T. M., & Lie, D. C. (2007) · Cell and Tissue Research · doi:10.1007/s00441-007-0476-5 · Cited by 84
“2002) as well as the Nemo-like kinases, which decrease the DNA-binding affinity of the Tcf/LEF/β-cat complex (Ishitani et al. 2003; Lo et al. 2004).”
BackgroundSALL4 is directly activated by TCF/LEF in the canonical Wnt signaling pathway
Böhm, J., Sustmann, C., Wilhelm, C., & Kohlhase, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.07.124 · Cited by 78
Mao, C. D., & Byers, S. W. (2011) · Critical Reviews in Eukaryotic Gene Expression · doi:10.1615/critreveukargeneexpr.v21.i3.10 · Cited by 74
Srivastava, R., Zhang, J., Go, G., Narayanan, A., Nottoli, T., & Mani, A. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.028 · Cited by 74
Nemo-like kinase, a multifaceted cell signaling regulator
Ishitani, T., & Ishitani, S. (2013) · Cellular Signalling · doi:10.1016/j.cellsig.2012.09.017 · Cited by 71
Self-citationβ-Catenin-Independent Wnt Pathways: Signals, Core Proteins, and Effectors
James, R. G., Conrad, W. H., & Moon, R. T. (2008) · Methods in molecular biology · doi:10.1007/978-1-59745-249-6_10 · Cited by 71
Nemo‐like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells
Emami, K. H., Brown, L. G., Pitts, T. E. M., Sun, X., Vessella, R. L., & Corey, E. (2009) · The Prostate · doi:10.1002/pros.20998 · Cited by 69
“These observations contrast with results in the TCF-4 and NF-κB systems, where NLK inhibits signaling of these transcription factors, but their levels are not decreased [26,34].”
ResultPietersen, C. Y., Mauney, S. A., Kim, S. S., Passeri, E., Lim, M. P., Rooney, R. J., Goldstein, J. M., Petryshen, T. L., Seidman, L. J., Shenton, M. E., et al. (2014) · Journal of Neurogenetics · doi:10.3109/01677063.2013.878339 · Cited by 67
Jing, L., Wang, F., Liu, C., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1174-3 · Cited by 67
“Many factors have been identified to interact with the β-catenin-TCF4/LEF-1 complex, which then recruits the transcription factors Brg1 and CREB-binding protein to initiate Wnt-targeted gene expression, such as lncRNA CRNDE, Nemo-like kinase, and APC [25] [26] [27] .”
BackgroundZeng, Y. A., Rahnama, M., Wang, S. J. H., Sosu-Sedzorme, W., & Verheyen, E. M. (2007) · Development · doi:10.1242/dev.02853 · Cited by 65
“Others have found that the kinase activity of Nlk is stimulated by Tak1 after Wnt induction (Ishitani et al., 2003a; Smit et al., 2004; Kanei-Ishii et al., 2004) and that Tak1 can be activated by BMP signaling (Yamaguchi et al., 1995).”
BackgroundInfluentialKuo, P.-Y., Leshchenko, V. V., Fazzari, M. J., Perumal, D., Gellen, T. A., He, T., Iqbal, J., Baumgartner-Wennerholm, S., Nygren, L., Zhang, F., et al. (2014) · Oncogene · doi:10.1038/onc.2014.44 · Cited by 63
Osei-Sarfo, K., & Gudas, L. J. (2014) · Stem Cells · doi:10.1002/stem.1706 · Cited by 62
Wnt11/Fgfr1b cross-talk modulates the fate of cells in palate development
Lee, J., Kim, J., Cho, K., et al. (2008) · Developmental Biology · doi:10.1016/j.ydbio.2007.11.033 · Cited by 62
The regulation of osteoclast differentiation by Wnt signals
Kobayashi, Y., Uehara, S., Koide, M., & Takahashi, N. (2015) · BoneKEy Reports · doi:10.1038/bonekey.2015.82 · Cited by 63
Nemo is an inducible antagonist of Wingless signaling during Drosophila wing development
Zeng, Y. A., & Verheyen, E. M. (2004) · Development · doi:10.1242/dev.01177 · Cited by 60
Wnt Pathway: An Integral Hub for Developmental and Oncogenic Signaling Networks
Sharma, M., & Pruitt, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21218018 · Cited by 57
“Another study provided evidence that Wnt5a represses ribosomal RNA (rRNA) synthesis by promoting DVL-1 accumulation in nucleolus of breast cancer cells, where nucleolar DVL-1 releases Pol I transcription activator and SIRT7 from rDNA loci, thereby inhibiting tumor growth [119].”
BackgroundLiu, B. Y., Kim, Y. C., Leatherberry, V., Cowin, P., & Alexander, C. M. (2003) · Oncogene · doi:10.1038/sj.onc.1207217 · Cited by 57
“In both mammalian cells and model organisms, other pathways have been shown to modulate TCF-dependent activity, such as EGF (Payre et al., 1999), TGF-b (Nishita et al., 2000; Letamendia et al., 2001) and MAPKs (Ishitani et al., 1999; Behrens, 2000; Ishitani et al., 2003).”
BackgroundNLK phosphorylates Raptor to mediate stress-induced mTORC1 inhibitionPreprint
Yuan, H.-X., Wang, Z., Yu, F., Li, F., Russell, R. C., Jewell, J. L., & Guan, K. (2015) · Genes & Development · doi:10.1101/gad.265116.115 · Cited by 61
“Previous studies have suggested that TAK1 is an upstream activating kinase of NLK (Ishitani et al. 1999, 2003a; Kanei-Ishii et al. 2004; Ohkawara et al. 2004; Smit et al. 2004).”
BackgroundNemo-like kinase induces apoptosis in DLD-1 human colon cancer cells
Yasuda, J., Tsuchiya, A., Yamada, T., Sakamoto, M., Sekiya, T., & Hirohashi, S. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01343-3 · Cited by 56
Jung, K. H., Kim, J. K., Noh, J. H., Eun, J. W., Bae, H. J., Xie, H. J., Ahn, Y. M., Park, W. S., Lee, J. Y., & Nam, S. W. (2010) · Journal of Cellular Biochemistry · doi:10.1002/jcb.22579 · Cited by 55
“…progression of liver cancer, recent studies have reported genetic alterations of tumor suppressor genes and oncogenes such as p53, pRb, b-catenin, and AXIN1 associated with hepatocarcinogenesis [de La Coste et al., 1998; Satoh et al., 2000; Thorgeirsson and Grisham, 2002; Ishitani et al., 2003a].”
BackgroundRegulation of β‐Catenin Nuclear Dynamics by GSK‐3β Involves a LEF‐1 Positive Feedback Loop
Jamieson, C., Sharma, M., & Henderson, B. R. (2011) · Traffic · doi:10.1111/j.1600-0854.2011.01207.x · Cited by 52
Röttinger, E., Croce, J., Lhomond, G., Besnardeau, L., Gache, C., & Lepage, T. (2006) · Development · doi:10.1242/dev.02603 · Cited by 54
A Wnt kinase network alters nuclear localization of TCF-1 in colon cancer
Najdi, R., Syed, A. O., Arce, L., Theisen, H., Ting, J.-H., Atcha, F. A., Nguyen, A. V., Martinez, M. E., Holcombe, R. F., Edwards, R. A., et al. (2009) · Oncogene · doi:10.1038/onc.2009.271 · Cited by 53
“However, current models place Wnt signaling upstream of CaMKII signaling (Ishitani et al. , 2003a; Kohn and Moon, 2005; Lo et al. , 2004).”
InfluentialRegulation of FOXO1 by TAK1-Nemo-like Kinase Pathway
Kim, S., Kim, Y., Lee, J., & Chung, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.101824 · Cited by 52
Contreras, O., Soliman, H. S., Théret, M., Rossi, F. M. V., & Brandan, E. (2020) · Journal of Cell Science · doi:10.1242/jcs.242297 · Cited by 52
HIC-5 Is a Novel Repressor of Lymphoid Enhancer Factor/T-cell Factor-driven Transcription
Ghogomu, S. M., van Venrooy, S., Ritthaler, M., Wedlich, D., & Gradl, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m505869200 · Cited by 49
Fleskens, V., Minutti, C. M., Wu, X., Wei, P., Pals, C. E. G. M., McCrae, J., Hemmers, S., Groenewold, V., Vos, H.-J., Rudensky, A., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.02.087 · Cited by 49
“Ionomycin triggers intracellular Ca release, which was previously demonstrated to induce Ca/calmodulin-dependent kinase (CaMKII) to directly phosphorylate TAK1, thereby inducing TAK1 signaling (Ishitani et al., 2003; Wang et al., 2009).”
BackgroundComprehending the complex connection between PKCβ, TAK1, and IKK in BCR signaling
Shinohara, H., & Kurosaki, T. (2009) · Immunological Reviews · doi:10.1111/j.1600-065x.2009.00836.x · Cited by 49
Riz, I., & Hawley, R. G. (2005) · Oncogene · doi:10.1038/sj.onc.1208727 · Cited by 51
p15RS Attenuates Wnt/β-Catenin Signaling by Disrupting β-Catenin·TCF4 Interaction
Wu, Y., Zhang, Y., Zhang, H., Yang, X., Wang, Y., Ren, F., Huitu, L., Zhai, Y., Jia, B., Yu, J. Q., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.148791 · Cited by 48
Nemo‐like kinase suppresses a wide range of transcription factors, including nuclear factor‐kB
Yasuda, J., Yokoo, H., Yamada, T., Kitabayashi, I., Sekiya, T., & Ichikawa, H. (2004) · Cancer Science · doi:10.1111/j.1349-7006.2004.tb03170.x · Cited by 45
Employing New Cellular Therapeutic Targets for Alzheimers Disease: A Change for the Better?
Chong, Z. Z., Li, F., & Maiese, K. (2005) · Current Neurovascular Research · doi:10.2174/1567202052773508 · Cited by 45
Extra-Abdominal Desmoid Tumours: A Review of the Literature
Molloy, A. P., Hutchinson, B. D., & O'Toole, G. C. (2012) · Sarcoma · doi:10.1155/2012/578052 · Cited by 43
“Mutations of β-catenin can result in its stabilisation which in turn activates β-catenin-mediated T-cell factor/lymphoid enhancer factor-1-dependant transcription [22].”
BackgroundNoack, C., Zafeiriou, M.-P., Schaeffer, H. J., Renger, A., Pavlova, E., Dietz, R., Zimmermann, W., Bergmann, M., & Zelarayan, L. C. (2012) · EMBO Molecular Medicine · doi:10.1002/emmm.201101043 · Cited by 43
“Mechanistically, we found that KLF15 targets TCF4 to ubiquitination, which was previously shown for NLK (Ishitani et al, 2003).”
InfluentialMurine Frizzled-1 Behaves as an Antagonist of the Canonical Wnt/β-Catenin Signaling
Roman‐Roman, S., Shi, D., Stiot, V., Haÿ, E., Vayssière, B., Garcia, T., Baron, R., & Rawadi, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309233200 · Cited by 43
When prostate cancer meets bone: Control by wnts
Emami, K. H., & Corey, E. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.040 · Cited by 42
“elegans [19].”
Xiong, Y., Liu, Y. F., Song, Z., et al. (2013) · The Journal of Dermatology · doi:10.1111/1346-8138.12313 · Cited by 41
Verkaar, F., van der Doelen, A. A., Smits, J. F. M., Blankesteijn, W. M., & Zaman, G. J. R. (2011) · Chemistry & Biology · doi:10.1016/j.chembiol.2011.01.015 · Cited by 42
“Of these kinases, Nemo-like kinase (NLK) has been associated with inhibition of Wnt/b-catenin signaling (Ishitani et al., 1999; Ishitani et al., 2003), whereas CKId, and its closest homolog CKI3, have been demonstrated to be required for activation of Wnt/ b-catenin signaling (Peters et al.”
Background
Metadata
- Authors
- Ishitani, T., Ninomiya-Tsuji, J., & Matsumoto, K.
- Affiliations
- Nagoya University (JP)
- Department of Molecular Biology, Graduate School of Science, Nagoya University, and CREST, Japan Science and Technology Corporation, Chikusa-ku, Nagoya 464-8602, Japan
- Venue
- Molecular and Cellular Biology
- Publisher
- Informa UK Limited
- Published
- 2003-02-01
- Volume
- 23
- Issue
- 4
- Pages
- 1379-1389
- ISSN
- 0270-7306 (ISSN-L)
- 1098-5549
- PMC
- PMC141159
- OpenAlex
- W2113359377
- Semantic Scholar
- c5bd5fdc22c48d8a897ece5568678314f28893e2
- Cited by
- 212
- References
- 38
- Citations by year
- 2026: 2 · 2025: 7 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 3 · 2020: 6 · 2019: 6 · 2018: 3 · 2017: 8 · 2016: 7 · 2015: 11 · 2014: 14 · 2013: 11 · 2012: 13
- FWCI
- 4.93
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular and Cellular Biology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (submittedVersion)
- Funders
- Core Research for Evolutional Science and Technology
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Keywords
- Nemo-like kinase, TCF4, Wnt/β-catenin signaling, β-catenin, transcriptional repression, MAPK signaling, TAK1, serine/threonine phosphorylation, transcriptional activity, protein-protein interaction
- MeSH terms
- MAP Kinase Kinase Kinase 7, Amino Acid Sequence, Cells, Cultured, Cytoskeletal Proteins, DNA-Binding Proteins, Humans, Molecular Sequence Data, Mutation, Phosphorylation, Proto-Oncogene Proteins, Serine, Threonine, Transcription Factors, Valine, Signal Transduction, Trans-Activators, Down-Regulation, Protein Serine-Threonine Kinases, Sequence Homology, Amino Acid, Amino Acid Substitution, Two-Hybrid System Techniques, Mitogen-Activated Protein Kinases, MAP Kinase Kinase Kinases, Zebrafish Proteins, Intracellular Signaling Peptides and Proteins, Wnt Proteins, beta Catenin, TCF Transcription Factors, Lymphoid Enhancer-Binding Factor 1, Transcription Factor 7-Like 2 Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
A language model drew the claims from the paper on 2026-10-18, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-18 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
